Product
Adebelimumab
1 clinical trial
1 drug
1 indication
Indication
NSCLCDrug
AdebelimumabClinical trial
An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Lateral Ventricular Chemotherapy in Patients With Non-squamous NSCLC With Soft Meningeal Metastases Who Have Failed EGFR-TKI TherapyStatus: Recruiting, Estimated PCD: 2025-02-01